The motor signs of Parkinson's disease are thought to result in large part from a reduction of the level of dopamine in the basal ganglia. Over the last few years, many of the functional and anatomical consequences of dopamine loss in these structures have been identified, both in the basal ganglia and in related areas in thalamus and cortex. This knowledge has contributed significantly to our understanding of the link between the degeneration of dopamine neurons in the midbrain and the development of parkinsonism. This review discusses the evidence that implicates electrophysiologic changes (including altered discharge rates, increased incidence of burst firing, interneuronal synchrony, oscillatory activity, and altered sensorimotor processing) in basal ganglia, thalamus, and cortex, in parkinsonism. From these studies, parkinsonism emerges as a complex network disorder, in which abnormal activity in groups of neurons in the basal ganglia strongly affects the excitability, oscillatory activity, synchrony and sensory responses of areas of the cerebral cortex that are involved in the planning and execution of movement, as well as in executive, limbic or sensory functions. Detailed knowledge of these changes will help us to develop more effective and specific symptomatic treatments for patients with Parkinson's disease.
Introduction
The term 'Parkinson's disease' refers to a group of neurodegenerative conditions that affect several regions of the brain, including the pigmented nuclei in midbrain and brainstem, the olfactory tubercle, the cerebral cortex, and elements of the peripheral nervous system (e.g., Braak et al., 2006) . The earliest and most striking physical disabilities resulting from these changes are motor impairments that, together, are called 'parkinsonism'. These include paucity and slowness of movement (akinesia and bradykinesia), muscle stiffness (rigidity), and tremor at rest. In large part, these problems result from the prominent degeneration of dopaminergic neurons in the midbrain, and the consequent deficiency of dopamine in the brain areas that receive dopaminergic inputs from those neurons, specifically the post-commissural putamen and other basal ganglia regions. This review highlights some of the physiologic, anatomical and biochemical consequences of dopamine loss in the basal ganglia, which may be responsible for the emergence of parkinsonism. The study of these changes has been greatly facilitated by the availability of toxins with which highly selective dopamine loss can be induced in animals, including 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys and mice (Burns et al., 1983; Forno et al., 1993; Langston et al., 1983) , and 6-hydroxydopamine (6-OHDA) in rats and other animals (Simola et al., 2007; Ungerstedt, 1968; Ungerstedt and Arbuthnott, 1970) .
Circuit anatomy of the basal ganglia
Parkinsonism is considered to result primarily from abnormalities of basal ganglia function. The basal ganglia include the neostriatum (caudate nucleus and putamen), 
